Manulife prices $750M subordinated notes
Analysis based on 8 articles · First reported Jul 20, 2026 · Last updated Sep 01, 2026
The offering strengthens Manulife's Tier 2 capital base, supporting its regulatory capital position. The notes' pricing at par with a 6.146% coupon reflects current credit spreads and investor demand for insurance-sector debt.
Manulife Corporation priced a U.S. public offering of $750 million aggregate principal amount of 6.146% subordinated notes due 2041 at 100% of par. The notes, expected to be issued on September 11, 2026, are anticipated to qualify as Tier 2 regulatory capital. Interest is fixed at 6.146% until September 11, 2036, then resets to CMT Rate plus 1.350% until maturity in 2041. Manulife may redeem the notes with regulatory approval under certain conditions. Proceeds will be used for general corporate purposes, including potential refinancing. Meritz Securities, Citigroup, J.P. Morgan, and Morgan Stanley are joint book-running managers. The offering was made under a prospectus supplement filed with the SEC.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard